HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

becatecarin (XL 119)

a rebeccamycin deriviative
Also Known As:
XL 119; BM-27557-14; BMS 181176; BMS 181176-1; BMS 181176-14; BMS-181176; BMS-181176-1; BMS-181176-14; BMY 27557; BMY 27557-1; BMY 27557-14; BMY-27557; BMY-27557-1; DEAE-RBM; NSC 655649; NSC D640199; NSC-655649; NSC-D640199; XL-119; XL119 compound; becatecarin hydrochloride; becatecarin tartrate; diethylaminoethyl-rebeccamycin; rebeccamycin, diethylaminoethyl-
Networked: 12 relevant articles (0 outcomes, 6 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Kuhn, John G: 3 articles (03/2008 - 07/2003)
2. Moral, M A: 2 articles (05/2009 - 06/2008)
3. Tomillero, A: 2 articles (05/2009 - 06/2008)
4. Bernstein, Mark: 2 articles (03/2008 - 07/2003)
5. Ivy, Percy: 2 articles (03/2008 - 02/2003)
6. Langevin, Anne-Marie: 2 articles (03/2008 - 07/2003)
7. Ambudkar, Suresh V: 1 article (08/2009)
8. Bahr, Julian C: 1 article (08/2009)
9. Bates, Susan E: 1 article (08/2009)
10. Di Pietro, Attilio: 1 article (08/2009)

Related Diseases

1. Neoplasms (Cancer)
2. Colorectal Neoplasms (Colorectal Cancer)
3. Hepatitis C
09/01/2006 - "The data in the following tables have been retrieved from the Clinical Trials Knowledge Area of Prous Science Integrity, the drug discovery and development portal, http://integrity.prous.com This issue focuses on the following selection of drugs: A-007, A6, adalimumab, adenosine triphosphate, alefacept, alemtuzumab, AllerVax Ragweed, amphora, anakinra, angiotensin-(1-7), anidulafungin, apomine, aripiprazole, atomoxetine hydrochloride, avanafil; BAL-8557, becatecarin, bevacizumab, biphasic insulin aspart, BMS-188797, bortezomib, bosentan, botulinum toxin type B, brivudine; Calcipotriol/betamethasone dipropionate, caspofungin acetate, catumaxomab, certolizumab pegol, cetuximab, CG-0070, ciclesonide, cinacalcet hydrochloride, clindamycin phosphate/benzoyl peroxide, cryptophycin 52, Cypher; Dabigatran etexilate, darapladib, darbepoetin alfa, decitabine, deferasirox, desloratadine, dexanabinol, dextromethorphan/quinidine sulfate, DMF, drotrecogin alfa (activated), duloxetine hydrochloride; E-7010, edaravone, efalizumab, emtricitabine, entecavir, eplerenone, erlotinib hydrochloride, escitalopram oxalate, estradiol valerate/dienogest, eszopiclone, exenatide, ezetimibe; Fondaparinux sodium, fulvestrant; Gefitinib, gestodene, GYKI-16084; Hyaluronic acid, hydralazine hydrochloride/isosorbide dinitrate; Imatinib mesylate, indiplon, insulin glargine; Juzen-taiho-to; Lamivudine/zidovudine/abacavir sulfate, L-arginine hydrochloride, lasofoxifene tartrate, L-BLP-25, lenalidomide, levocetirizine, levodopa/carbidopa/entacapone, lexatumumab, lidocaine/prilocaine, lubiprostone, lumiracoxib; MAb-14.18, mitoquidone; Natalizumab, neridronic acid, neuradiab; Olpadronic acid sodium salt, omalizumab; p53-DC vaccine, parathyroid hormone (human recombinant), peginterferon alfa-2a, peginterferon alfa-2b, pemetrexed disodium, perifosine, pimecrolimus, prasterone, prasugrel, PRO-2000, Pseudostat; R24, rasburicase, RHAMM R3 peptide, rilonacept, rosuvastatin calcium, rotavirus vaccine, rufinamide; Sabarubicin hydrochloride, SHL-749, sirolimus-eluting stent, SLx-2101, sodium butyrate, sorafenib, SU-6668; TachoSil, tadalafil, taxus, tegaserod maleate, telbivudine, tenofovir disoproxil fumarate, teriparatide, tetramethylpyrazine, teverelix, tiotropium bromide, tipifarnib, tirapazamine, tolvaptan, TransvaxTM hepatitis C vaccine, treprostinil sodium; Valganciclovir hydrochloride, valsartan/amlodipine, vandetanib, vardenafil hydrochloride hydrate, vatalanib succinate, veglin, voriconazole; Yttrium 90 (90Y) ibritumomab tiuxetan; Zileuton, zotarolimus, zotarolimus-eluting stent."
4. Neuroblastoma
5. Thrombocytopenia (Thrombopenia)

Related Drugs and Biologics

1. rebeccamycin
2. Amlodipine (Norvasc)
3. Sodium
4. Salts
5. Escitalopram
6. Decitabine
7. Sorafenib (BAY 43-9006)
8. Gefitinib (Iressa)
9. Alemtuzumab (Campath)
10. Erlotinib Hydrochloride (CP 358,774)

Related Therapies and Procedures

1. Stents
2. Therapeutics